Matinas BioPharma Holdings (MTNB) Goodwill & Intangibles (2015 - 2026)

Matinas BioPharma Holdings (MTNB) has reported Goodwill & Intangibles for 12 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles changed 0.0% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (changed 0.0% YoY), while the FY2025 annual figure was $2.3 million, changed 0.0% from the prior year.
• Goodwill & Intangibles held at $2.3 million in Q1 2026 per MTNB's latest filing, from $2.3 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $4.4 million in Q1 2022 and bottomed at $2.3 million in Q4 2024.
• Historically, Goodwill & Intangibles has averaged $3.6 million across 5 years, with a median of $4.4 million in 2022.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles changed 0.0% — and 2024, when it sank 48.08%.
• Matinas BioPharma Holdings' Goodwill & Intangibles stood at $4.4 million in 2022, then changed by 0.0% to $4.4 million in 2023, then tumbled by 48.08% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025, then changed by 0.0% to $2.3 million in 2026.
• Business Quant data shows MTNB's Goodwill & Intangibles at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.